CT Acquisition Protocol Groundwork: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
New page: Goal: ==Proposed Protocol== ==Related Work== ===Defining Acquisition Protocols=== ACRIN has defined a number of protocols for CT-based clinical trials. * [[:Media:Cagnon_NLST_QA_Pro...
 
No edit summary
Line 3: Line 3:


==Proposed Protocol==
==Proposed Protocol==
Q. Should we propose two protocols 1) for high resolution; and (2) for world-wide trials in patients with late stage disease?




Line 16: Line 18:


UPICT is preparing a process for proposing/reviewing protocols and has access to experts for reviews.
UPICT is preparing a process for proposing/reviewing protocols and has access to experts for reviews.
It would likely be beneficial to review our proposed protocols with them.


===Storing/Transfering Acquisition Protocols===
===Storing/Transfering Acquisition Protocols===


DICOM is working on a format for encoding acquisition protocols as DICOM objects which can be stored/retrieved.
DICOM is working on a format for encoding acquisition protocols as DICOM objects which can be stored/retrieved.
===Field Testing Acquisition Protocols===
Q. Should we broadcast our proposed protocols for general use in pharma trials that are starting up now, before we complete our profiles and groundwork?

Revision as of 04:00, 13 December 2008

Goal:


Proposed Protocol

Q. Should we propose two protocols 1) for high resolution; and (2) for world-wide trials in patients with late stage disease?


Related Work

Defining Acquisition Protocols

ACRIN has defined a number of protocols for CT-based clinical trials.

Reviewing Acquisition Protocols

UPICT is preparing a process for proposing/reviewing protocols and has access to experts for reviews.

It would likely be beneficial to review our proposed protocols with them.

Storing/Transfering Acquisition Protocols

DICOM is working on a format for encoding acquisition protocols as DICOM objects which can be stored/retrieved.

Field Testing Acquisition Protocols

Q. Should we broadcast our proposed protocols for general use in pharma trials that are starting up now, before we complete our profiles and groundwork?